The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.
Saved in:
| Title: | The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial. |
|---|---|
| Authors: | Fisk, Marie1 mf503@medschl.cam.ac.uk, Cheriyan, Joseph1,2, Mohan, Divya3,4, Forman, Julia2, Mäki-Petäjä, Kaisa M.1, McEniery, Carmel M.1, Fuld, Jonathan5, Rudd, James H. F.6, Hopkinson, Nicholas S.3, Lomas, David A.7, Cockcroft, John R.8, Tal-Singer, Ruth4, Polkey, Michael I.2, Wilkinson, Ian B.1 |
| Source: | PLoS ONE. 3/22/2018, Vol. 13 Issue 3, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0194197 |
